DexCom
DXCM
#744
Rank
HK$212.44 B
Marketcap
HK$543.90
Share price
1.52%
Change (1 day)
-24.62%
Change (1 year)

P/E ratio for DexCom (DXCM)

P/E ratio as of November 2024 (TTM): 72.1

According to DexCom's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 72.0956. At the end of 2022 the company had a P/E ratio of 129.

P/E ratio history for DexCom from 2005 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022129-49.43%
2021254258.6%
202071.0-64.64%
2019201-341.22%
2018-83.2-14.47%
2017-97.327.09%
2016-76.5-31.78%
2015-112-38.86%
2014-184117.65%
2013-84.3390.1%
2012-17.225.65%
2011-13.7-0.7%
2010-13.8105.02%
2009-6.73387.32%
2008-1.38-74.68%
2007-5.45-5.47%
2006-5.7731.79%
2005-4.38

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
28.3-60.76%๐Ÿ‡บ๐Ÿ‡ธ USA
41.9-41.88%๐Ÿ‡บ๐Ÿ‡ธ USA
43.1-40.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-9.69-113.44%๐Ÿ‡บ๐Ÿ‡ธ USA
32.4-55.06%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
39.3-45.49%๐Ÿ‡บ๐Ÿ‡ธ USA
11.1-84.63%๐Ÿ‡บ๐Ÿ‡ธ USA
220 204.53%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.